Literature DB >> 30190874

Lymph nodes and the melanoma surgeon: re-defining a long-term relationship.

Mary S Brady1.   

Abstract

Surgeons now have an enhanced ability to stage patients with clinically localized cutaneous melanoma using sentinel lymph node biopsy. Despite this, the weight of clinical evidence is tilting in favor of a measured approach to pre-emptive lymph node removal. Careful consideration of whether traditional surgical approaches to the regional nodes, whether done in the name of 'staging' or pre-emptive removal of a potential site of relapse, really 'benefit' the patient is paramount for optimal care.

Entities:  

Keywords:  SLN; completion; elective; lymph node; lymphadenectomy; melanoma; nodal disease; sentinel lymph node mapping; staging

Year:  2016        PMID: 30190874      PMCID: PMC6094669          DOI: 10.2217/mmt.15.42

Source DB:  PubMed          Journal:  Melanoma Manag        ISSN: 2045-0885


  32 in total

1.  Caution with sentinel node biopsy in cutaneous melanoma.

Authors:  J M Thomas
Journal:  Br J Surg       Date:  2006-02       Impact factor: 6.939

2.  Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy.

Authors:  Kimberly M Dalal; Ami Patel; Mary S Brady; David P Jaques; Daniel G Coit
Journal:  Ann Surg Oncol       Date:  2007-04-04       Impact factor: 5.344

3.  Frequency of nonsentinel lymph node metastasis in melanoma.

Authors:  Kelly M McMasters; Sandra L Wong; Michael J Edwards; Celia Chao; Merrick I Ross; R Dirk Noyes; Vicki Viar; Patricia B Cerrito; Douglas S Reintgen
Journal:  Ann Surg Oncol       Date:  2002-03       Impact factor: 5.344

4.  Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study.

Authors:  F H Sim; W F Taylor; D J Pritchard; E H Soule
Journal:  Mayo Clin Proc       Date:  1986-09       Impact factor: 7.616

5.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.

Authors:  Héctor Peinado; Maša Alečković; Simon Lavotshkin; Irina Matei; Bruno Costa-Silva; Gema Moreno-Bueno; Marta Hergueta-Redondo; Caitlin Williams; Guillermo García-Santos; Cyrus Ghajar; Ayuko Nitadori-Hoshino; Caitlin Hoffman; Karen Badal; Benjamin A Garcia; Margaret K Callahan; Jianda Yuan; Vilma R Martins; Johan Skog; Rosandra N Kaplan; Mary S Brady; Jedd D Wolchok; Paul B Chapman; Yibin Kang; Jacqueline Bromberg; David Lyden
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

6.  Sentinel lymphadenectomy for patients with clinical stage I melanoma.

Authors:  D L Morton
Journal:  J Surg Oncol       Date:  1997-12       Impact factor: 3.454

7.  Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harold J Hoekstra; Constantine P Karakousis; Christopher A Puleo; Brendon J Coventry; Mohammed Kashani-Sabet; B Mark Smithers; Eberhard Paul; William G Kraybill; J Gregory McKinnon; He-Jing Wang; Robert Elashoff; Mark B Faries
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245

8.  Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.

Authors:  J E Gershenwald; M I Colome; J E Lee; P F Mansfield; C Tseng; J J Lee; C M Balch; M I Ross
Journal:  J Clin Oncol       Date:  1998-06       Impact factor: 44.544

9.  Nivolumab plus ipilimumab in advanced melanoma.

Authors:  Jedd D Wolchok; Harriet Kluger; Margaret K Callahan; Michael A Postow; Naiyer A Rizvi; Alexander M Lesokhin; Neil H Segal; Charlotte E Ariyan; Ruth-Ann Gordon; Kathleen Reed; Matthew M Burke; Anne Caldwell; Stephanie A Kronenberg; Blessing U Agunwamba; Xiaoling Zhang; Israel Lowy; Hector David Inzunza; William Feely; Christine E Horak; Quan Hong; Alan J Korman; Jon M Wigginton; Ashok Gupta; Mario Sznol
Journal:  N Engl J Med       Date:  2013-06-02       Impact factor: 91.245

10.  Is complete lymph node dissection after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? A meta-analysis.

Authors:  V Nagaraja; G D Eslick
Journal:  Eur J Surg Oncol       Date:  2013-04-06       Impact factor: 4.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.